
Full text loading...
Category: Bacterial Pathogenesis; Clinical Microbiology
Perspectives for Developing New Tuberculosis Vaccines Derived from the Pathogenesis of Tuberculosis, Page 1 of 2
< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555819866/9781555819859_Chap03-1.gif /docserver/preview/fulltext/10.1128/9781555819866/9781555819859_Chap03-2.gifAbstract:
The perspectives described in this chapter address both preclinical tuberculosis (TB) in animal hosts and clinical TB in human populations. They are a guide to how new TB vaccines can be more effectively evaluated in each group. This chapter is not a review of new TB vaccines or the mechanisms in which they may reduce the prevalence or morbidity of TB in the world.
Full text loading...
Protective efficacy, DTH response, and CMI response induced by current TB vaccines in preclinical and in clinical trials a
Protective efficacy, DTH response, and CMI response induced by current TB vaccines in preclinical and in clinical trials a